Putting Our Heads Together
Posted in Early Detection, News on Feb 27th, 2008
By now, pretty much everyone agrees: Screening means early detection, and early detection saves lives. “So why not screen for brain tumors?” Dr. Patrick J. Kelly was asking the other day. “It’s easy to do. Low-cost screening is available. You could save many, many lives.”
Posted in News on Feb 27th, 2008
After the surgical removal of a malignant tumor, the chance that cancer will re-appear in a different location of the body remains high. But new research from Tel Aviv University, in a bold new field called Psychoneuroimmunology, may prevent those cancer cells from taking root again — and the key to the treatment is stress reduction.
Hassenbusch succumbed to glioblastoma at home, nearly three years after he was diagnosed and nine months after cancerous cells recurred. Throughout, he was a forceful spokesman who believed that, in his words, “life doesn’t have to end just because you have cancer.”
Bradmer Pharmaceuticals Inc., a biopharmaceutical company dedicated to the development and commercialization of cancer therapies, today announced that Phase II data on the Company’s Neuradiab product candidate as a treatment for newly diagnosed glioblastoma multiforme (GBM) were published in the journal, Neuro-Oncology.
Northern Illinois University won state permission Tuesday to build a $160 million proton-therapy cancer-treatment center in West Chicago, the first such facility in Illinois, but another is proposed only 6 miles away.
Posted in News on Feb 26th, 2008
Procedures to carry out a highly refined, complex radiation treatment for killing tumors and sparing healthy tissue may vary more widely from one medical center to the next than previously thought, a new study suggests.
Lixte Biotechnology Holdings, Inc. and its collaborator, the Surgical Neurology Branch (SNB), National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), reported at the 1st International Conference on Drug Discovery and Development, Dubai, UAE, February 6, 2008, that its lead compound LB-1, one of a patent-pending proprietary series of agents, has anti-cancer activity against medulloblastoma cells growing in culture and in a mouse model of cancer.
Stepping up treatment for children with a deadly brain cancer can dramatically improve survival, British researchers reported today.
Close friends, the two families have been through similar situations with very different outcomes. Carter has been in remission since September. Declared “cancer free,” he will lead a healthy life with the memories of his infancy, hopefully, fading with time. The Faraones lost their son, Christopher, to brain cancer when he was 3. After a chemical cocktail of chemotherapy ruined Christopher’s kidneys and sessions of radiation were unsuccessful, the Faraones were praying for a miracle that never came.
Posted in Legislation, News on Feb 21st, 2008
A Senate committee passed “Steffanie’s Law” today to require insurance companies to cover medical costs such as lab tests and doctor’s visits associated with clinical trials that test new medical treatments for such things as cancer.
